Gentamicin and tetracyclines for the treatment of human plague: review of 75 cases in new Mexico, 1985-1999

Clicks: 291
ID: 271358
2004
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #159 of 562 articles by views in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 562 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Streptomycin, an antimicrobial with limited availability, is the treatment of choice for plague, a fulminating and potentially epidemic disease that poses a bioterrorism concern. We evaluated the efficacy of gentamicin and tetracyclines for treating human plague. A medical record review was conducte …
Reference Key
ll2004clinicalgentamicin Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Boulanger LL;Ettestad P;Fogarty JD;Dennis DT;Romig D;Mertz G;;
Journal Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Year 2004
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/14986250
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine adult female male Comparative Study Retrospective Studies length of stay drug therapy combination / therapeutic use* plague / complications plague / drug therapy* plague / mortality gentamicins / therapeutic use* streptomycin / therapeutic use pmid:14986250 doi:10.1086/381545 l lucy boulanger paul ettestad gregory mertz tetracyclines / therapeutic use* yersinia pestis / drug effects

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.